Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019:23:18-059.
doi: 10.7812/TPP/18-059.

Progel Use is Not Associated with Decreased Incidence of Postoperative Air Leak after Nonanatomic Lung Surgery

Rebecca C Gologorsky  1 , Amy L Alabaster  2 , Simon K Ashiku  2 , Ashish R Patel  2 , Jeffrey B Velotta  2
Affiliations

Progel Use is Not Associated with Decreased Incidence of Postoperative Air Leak after Nonanatomic Lung Surgery

Rebecca C Gologorsky et al. Perm J. 2019.

Abstract

Context: Progel Pleural Air Leak Sealant (CR Bard, Warwick, RI) is a US Food and Drug Administration-approved hydrogel designed for application to surgical staple lines to prevent air leak after lung surgery. This product has demonstrated efficacy in reducing intraoperative air leaks compared with standard air leak closure methods. However, the impact on chest tube duration and length of hospital stay has not been reported.

Objective: To evaluate the effect on rates of postoperative air leak, chest tube duration, and hospital stay in surgical patients with and without use of Progel.

Design: Retrospective study of 176 patients aged 18 to 80 years who underwent video-assisted thoracoscopic wedge resections between 2014 and 2016. Eighty-four (48%) cases using Progel were included, as well as a representative sample of non-Progel cases (n = 92; 52%).

Main outcome measure: Presence of postoperative lung air leak.

Results: No difference existed between the Progel and non-Progel groups in the rate of postoperative air leak (20/84, 23.81% Progel; 16/92, 17.39% non-Progel; p = 0.33). The length of time patients had a chest tube was similar (23.5 vs 23 hours, p = 0.721), as was percentage of patients with a less than 2-day hospitalization (77.17% non-Progel vs 82.14% Progel, p = 0.414).

Conclusion: Our results suggest that Progel, used routinely in patients undergoing nonanatomic lung resection, does not have a significant impact on postoperative air leak, chest tube duration, or length of hospital stay. Further studies are warranted to evaluate the utility of Progel in reducing postoperative complications after thoracoscopic wedge resection in those treated for air leak or in the reduction of postoperative air leak in high-risk patients.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement

The author(s) have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Patient selection for Progel and non-Progel groups.
See this image and copyright information in PMC

References

    1. Elsayed H, McShane J, Shackcloth M. Air leaks following pulmonary resection for cancer: Is it a patient or surgeon related problem? Ann R Coll Surg Engl. 2012 Sep;94(6):422–7. - PMC - PubMed
    1. Mueller MR, Marzluf BA. The anticipation and management of air leaks and residual space post lung resection. J Thorac Dis. 2014 Mar;6(3):271–84. doi: 10.3978/j.issn.2072-1439.2013.11.29. - DOI - PMC - PubMed
    1. Yoo A, Ghosh SK, Danker W, Kassis E, Kalsekar I. Burden of air leak complications in thoracic surgery estimated using a national hospital billing database. Clinicoecon Outcomes Res. 2017 Jun 29;9:373–83. doi: 10.2147/CEOR.S133830. - DOI - PMC - PubMed
    1. Rivera C, Bernard A, Falcoz P-E, et al. Characterization and prediction of prolonged air leak after pulmonary resection: A nationwide study setting up the index of prolonged air leak. Ann Thorac Surg. 2011 Sep;92(3):1062–8. doi: 10.1016/j.athoracsur.2011.04.033. - DOI - PubMed
    1. Belda-Sanchís J, Serra-Mitjans M, Iglesias Sentis M, Rami R. Surgical sealant for preventing air leaks after pulmonary resections for patients with lung cancer. Cochrane Database Syst Rev. 2010 Jan;20(1):CD003051. doi: 10.1002/14651858.CD003051.pub3. - DOI - PMC - PubMed

Substances